This bit here I really like -
"The two parties bring complementary skills and assets to the proposed Joint Venture. Zishan will take on the functions of sales, account management, marketing and promotion of GTG’s genetic risk assessment products for the Chinese market. Zishan and its associated entities have strong relationships with the Chinese government and will be an effective liaison between GTG and the China Food and Drug Administration (CFDA). "
I see a cash cow on the horizon. IMO
Ann: Proposed JV with Beijing Zishan Health Consultancy Limited, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
